Unknown

Dataset Information

0

Low Utilization of Androgen Deprivation Therapy Among Men Receiving Stereotactic Body Radiotherapy for Localized Prostate Cancer in the United States.

ABSTRACT:

SUBMITTER: Royce TJ 

PROVIDER: S-EPMC7775872 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
| S-EPMC3038121 | biostudies-literature
Unknown Survival following primary androgen deprivation therapy among men with localized prostate cancer.
| S-EPMC2645653 | biostudies-literature
Unknown Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.
| S-EPMC4543371 | biostudies-literature
Unknown Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.
| S-EPMC3047407 | biostudies-literature
Unknown A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
| S-EPMC3352294 | biostudies-literature
Unknown Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy.
| S-EPMC8142939 | biostudies-literature
Unknown Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR).
| S-EPMC7542889 | biostudies-literature
Unknown Stereotactic body radiotherapy versus conventional/moderate fractionated radiation therapy with androgen deprivation therapy for unfavorable risk prostate cancer.
| S-EPMC7493337 | biostudies-literature
Transcriptomics Genomic profile of fatigued men receiving localized radiation therapy
2015-06-17 | GSE69961 | GEO
Unknown Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
| S-EPMC2900763 | biostudies-literature